ArticleScientific reports2025
The association between glycemic indicators and bone mineral density and osteoporosis: a cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Sex differences in the association between bone mineral density and lipid profiles in people with type 2 diabetes in southwest China.Metabolism open · 2026Article
- Glycated hemoglobin and bone mineral density in adults with and without type 2 diabetes: a cross-sectional DXA study from the Qassim region, Saudi Arabia.BMC endocrine disorders · 2026Article
- Development and validation of a robust logistic regression model for predicting osteoporosis in older people.Frontiers in medicine · 2026Article
- Relationship Between Serum Melatonin Levels and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus.Clinical medicine insights. Endocrinology and diabetes · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To investigate the relationship between glycemic indicators (HbA1c and FPG) and bone mineral density (BMD) as well as osteoporosis in adults. A total of 1445 participants from the "The longitudinal investigation of osteoarthritis and cardiovascular health status" cohort were recruited and classified into normal BMD, osteopenia, and osteoporosis groups based on BMD. Data on sociodemographic factors, anthropometric measurements, medical history, and FPG samples were collected. BMD was measured by tibial ultrasound. Logistic regression analysis was performed to calculate the Odds Ratio (OR) and 95% confidence interval (CI), with adjustments for confounding factors. Participants in the osteopenia and osteoporosis groups were older, had higher triglycerides and body mass index, and fewer smokers and alcohol consumers compared to the normal BMD group. HbA1c levels were significantly lower in the osteopenia and osteoporosis groups than in the normal BMD group, while FPG showed no significant differences. Logistic regression indicated a significant negative correlation between HbA1c and the risk of osteoporosis (OR (95% CI) 0.914 (0.838, 0.997)) and osteopenia (OR (95% CI) 0.904 (0.826, 0.989)). After adjusting for confounding factors, a significant positive correlation exists between HbA1c and BMD, and higher HbA1c levels are associated with a relatively lower risk of osteoporosis. These findings highlight the importance of considering long-term blood glucose control in clinical practice for bone health management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.